Efficiency of TISSEEL for Sleeve Gastrectomy Complications
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Jun 6, 2012
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
The hypothesis is the following : the use of fibrin glue (Tissucol ®) during Laparoscopic Sleeve Gastrectomy would reduce the incidence of complications (gastric fistula, intra-abdominal hemorrhage and intra-abdominal locoregional collection).
The aim is to investigate whether the use of fibrin glue (Tissucol®) during Laparoscopic Sleeve Gastrectomy reduces the incidence of postoperative complications (gastric fistula, intra-abdominal hemorrhage and intra-abdominal locoregional collection)
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Obesity requiring bariatric surgery (Laparoscopic Sleeve Gastrectomy) according to the Haute Autorité de Santé
- • Patients younger than 60 years old
- • BMI ≤ 60 kg/m2
- • Surgery accepted by an Obesity-related specific committee
- • Patient with social protection
- Exclusion Criteria:
- • Previous bariatric or gastric surgery
- • BMI \> 60 kg/m2
- • Under 18 years old
- • Allergy to Tissucol®
- • peroperative fistula
- • Consent not signed
- • Incapable of giving his opinion
- • Pregnancy or breast-feeding
- • Contraindication to surgery
- • ASA classification IV
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Rouen, , France
Patients applied
Trial Officials
Jean-Marc REGIMBEAU, MD,phD
Principal Investigator
chu amiens
michel scotte, MD PhD
Principal Investigator
chu Rouen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials